Search

Date 2020 Author/Creator Scheithauer, Werner

1. Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer. (14th December 2020)

Authors:
Sobrero, Alberto; Lenz, Heinz‐Josef; Eng, Cathy; Scheithauer, Werner; Middleton, Gary; Chen, Wenfeng; Esser, Regina; Nippgen, Johannes; Burris, Howard
Journal:
Oncologist
Issue:
Volume 26:Number 2(2021)
Page Start:
e261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC. (August 2020)

Authors:
Bianconi, Daniela; Herac, Merima; Posch, Florian; Schmeidl, Margit; Unseld, Matthias; Kieler, Markus; Brettner, Robert; Müllauer, Leonhard; Riedl, Jakob; Gerger, Armin; Scheithauer, Werner; Prager, Gerald
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. (September 2020)

Authors:
Stahler, Arndt; Stintzing, Sebastian; von Einem, Jobst C.; Westphalen, Christoph B. Benedikt; Heinrich, Kathrin; Krämer, Nicole; Michl, Marlies; Modest, Dominik P.; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, ...
Journal:
European journal of cancer
Issue:
Volume 137(2020)
Page Start:
250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗